Autoreactivity profiles of influenza hemagglutinin broadly neutralizing antibodies
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Autoreactivity profiles of influenza hemagglutinin broadly neutralizing antibodies ; volume:9 ; number:1 ; day:5 ; month:3 ; year:2019 ; pages:1-9 ; date:12.2019
Scientific reports ; 9, Heft 1 (5.3.2019), 1-9, 12.2019
- Creator
-
Bajic, Goran
Poel, Cees E. van der
Kuraoka, Masayuki
Schmidt, Aaron G.
Carroll, Michael C.
Kelsoe, Garnett
Harrison, Stephen C.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-019-40175-8
- URN
-
urn:nbn:de:101:1-2019032416044960942313
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:54 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Bajic, Goran
- Poel, Cees E. van der
- Kuraoka, Masayuki
- Schmidt, Aaron G.
- Carroll, Michael C.
- Kelsoe, Garnett
- Harrison, Stephen C.
- SpringerLink (Online service)
Other Objects (12)
A computationally optimized broadly reactive hemagglutinin vaccine elicits neutralizing antibodies against influenza B viruses from both lineages
Broadly Neutralizing Antibodies for HIV Eradication
Structural basis for a human broadly neutralizing influenza A hemagglutinin stem-specific antibody including H17/18 subtypes
The expanding array of HIV broadly neutralizing antibodies
Design clues from functional constraints and broadly neutralizing antibodies
Use of Hemagglutinin Stem Probes Demonstrate Prevalence of Broadly Reactive Group 1 Influenza Antibodies in Human Sera
Identification and characterization of broadly neutralizing antibodies targeting viral infections
Ultrapotent Broadly Neutralizing Human‐llama Bispecific Antibodies against HIV‐1
Broadly neutralizing antibodies and vaccine design against HIV-1 infection
Development of an anti-HIV vaccine eliciting broadly neutralizing antibodies
HIV-1 cell-to-cell transmission and broadly neutralizing antibodies
Use of equine H3N8 hemagglutinin as a broadly protective influenza vaccine immunogen
A computationally optimized broadly reactive hemagglutinin vaccine elicits neutralizing antibodies against influenza B viruses from both lineages
Broadly Neutralizing Antibodies for HIV Eradication
Structural basis for a human broadly neutralizing influenza A hemagglutinin stem-specific antibody including H17/18 subtypes
The expanding array of HIV broadly neutralizing antibodies
Design clues from functional constraints and broadly neutralizing antibodies
Use of Hemagglutinin Stem Probes Demonstrate Prevalence of Broadly Reactive Group 1 Influenza Antibodies in Human Sera
Identification and characterization of broadly neutralizing antibodies targeting viral infections
Ultrapotent Broadly Neutralizing Human‐llama Bispecific Antibodies against HIV‐1
Broadly neutralizing antibodies and vaccine design against HIV-1 infection
Development of an anti-HIV vaccine eliciting broadly neutralizing antibodies
HIV-1 cell-to-cell transmission and broadly neutralizing antibodies
Use of equine H3N8 hemagglutinin as a broadly protective influenza vaccine immunogen
A computationally optimized broadly reactive hemagglutinin vaccine elicits neutralizing antibodies against influenza B viruses from both lineages
Broadly Neutralizing Antibodies for HIV Eradication
Structural basis for a human broadly neutralizing influenza A hemagglutinin stem-specific antibody including H17/18 subtypes
The expanding array of HIV broadly neutralizing antibodies
Design clues from functional constraints and broadly neutralizing antibodies
Use of Hemagglutinin Stem Probes Demonstrate Prevalence of Broadly Reactive Group 1 Influenza Antibodies in Human Sera
Identification and characterization of broadly neutralizing antibodies targeting viral infections
Ultrapotent Broadly Neutralizing Human‐llama Bispecific Antibodies against HIV‐1
Broadly neutralizing antibodies and vaccine design against HIV-1 infection
Development of an anti-HIV vaccine eliciting broadly neutralizing antibodies
HIV-1 cell-to-cell transmission and broadly neutralizing antibodies